JPH02182193A - Production of 4-hydroxy-2-butynoic acid - Google Patents
Production of 4-hydroxy-2-butynoic acidInfo
- Publication number
- JPH02182193A JPH02182193A JP155389A JP155389A JPH02182193A JP H02182193 A JPH02182193 A JP H02182193A JP 155389 A JP155389 A JP 155389A JP 155389 A JP155389 A JP 155389A JP H02182193 A JPH02182193 A JP H02182193A
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy
- diol
- butyne
- butyric acid
- rhinocladiella
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- QVYMWMSAXULCMW-UHFFFAOYSA-N 4-hydroxybut-2-ynoic acid Chemical compound OCC#CC(O)=O QVYMWMSAXULCMW-UHFFFAOYSA-N 0.000 title 1
- 244000005700 microbiome Species 0.000 claims abstract description 20
- DLDJFQGPPSQZKI-UHFFFAOYSA-N but-2-yne-1,4-diol Chemical compound OCC#CCO DLDJFQGPPSQZKI-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000012258 culturing Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 15
- 239000000758 substrate Substances 0.000 claims description 9
- 241000223667 Rhinocladiella Species 0.000 abstract description 7
- 241000223670 Rhinocladiella atrovirens Species 0.000 abstract description 6
- 238000012136 culture method Methods 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 239000001963 growth medium Substances 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- FLJAFHRJXPAASR-LDTXXPTRSA-N (1r,4e,6s,7r,10e,14r)-4-(hydroxymethyl)-10,14-dimethyl-7-prop-1-en-2-yl-15-oxabicyclo[12.1.0]pentadeca-4,10-dien-6-ol Chemical compound C1C\C(CO)=C/[C@H](O)[C@@H](C(=C)C)CC\C(C)=C\CC[C@@]2(C)O[C@@H]21 FLJAFHRJXPAASR-LDTXXPTRSA-N 0.000 abstract description 2
- 229930183157 Asperdiol Natural products 0.000 abstract description 2
- FLJAFHRJXPAASR-UHFFFAOYSA-N Asperdiol A Natural products C1CC(CO)=CC(O)C(C(=C)C)CCC(C)=CCCC2(C)OC21 FLJAFHRJXPAASR-UHFFFAOYSA-N 0.000 abstract description 2
- 239000002246 antineoplastic agent Substances 0.000 abstract description 2
- 239000002609 medium Substances 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- -1 polypeptone Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 244000000000 soil microbiome Species 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- JSPXPZKDILSYNN-UHFFFAOYSA-N but-1-yne-1,4-diol Chemical compound OCCC#CO JSPXPZKDILSYNN-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000004688 heptahydrates Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- CDUFCUKTJFSWPL-UHFFFAOYSA-L manganese(II) sulfate tetrahydrate Chemical compound O.O.O.O.[Mn+2].[O-]S([O-])(=O)=O CDUFCUKTJFSWPL-UHFFFAOYSA-L 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
本発明は2−ブチン−1,4−ジオールからリノクラデ
ィエラ属に属する微生物により4−ヒドロキシ−2−ブ
チン酸を製造する方法に関する。
4−ヒドロキシ−2−ブチン酸は、分子内に水酸基、カ
ルボキシル基および三重結合を含むため有機化合物の合
成原料として有用であり、例えば抗腫瘍剤のアスペルジ
オールの出発物質(ジャーナル・オブ・オーガニック・
ケミストリー、48゜4785−4786 、1983
)として利用される。The present invention relates to a method for producing 4-hydroxy-2-butyric acid from 2-butyne-1,4-diol using a microorganism belonging to the genus Rhinocladia. 4-Hydroxy-2-butyric acid contains a hydroxyl group, a carboxyl group, and a triple bond in its molecule, so it is useful as a raw material for the synthesis of organic compounds.For example, it is used as a starting material for the antitumor drug asperdiol (Journal of Organic
Chemistry, 48°4785-4786, 1983
) is used as.
従来、4−ヒドロキシ−2−ブチン酸の製造方法として
は、以下のような化学的方法および微生物を用いる方法
か1例つつ知られている。
(1)硫酸酸性下、アセトン水溶液を溶媒とし2ブチン
−1,4−ジオールをクロム酸で酸化する方法(ソ連特
許第514806号明細書;ケミカル・アブストラクツ
、 85.123360e 、 (1976))。
(2)却−極性鞭毛を有し胞子非形成の土壌バクテリア
を用いて2−ブチン−1,4−ジオールを酸化して4−
ヒドロキシ−2−ブチン酸を製造する方法(醗酵工学雑
誌、 49(3)、 202−205゜(1971)
)。
(1)の化学的製法は、毒性の強いクロムを含む廃水処
理に問題かあり、工業的に実施しようとする場合公害面
での対策が必要である。
(2)の微生物を用いる方法は、4−ヒドロキシ2−ブ
チン酸の収量が10%未満と低いこと、選択率が低く目
的物以外の中性化合物が副成するなどの点で工業的実施
には不適当である。また、(2)の方法に用いられる微
生物は土壌バクテリアと記載されているのみで、菌学的
に明確に同定されていない。Conventionally, methods for producing 4-hydroxy-2-butyric acid have been known, including the following chemical method and method using microorganisms. (1) A method of oxidizing 2-butyne-1,4-diol with chromic acid under acidic sulfuric acid using acetone aqueous solution as a solvent (USSR Patent No. 514806; Chemical Abstracts, 85.123360e, (1976)). (2) Oxidize 2-butyne-1,4-diol using non-spore-forming soil bacteria with polar flagella to produce 4-
Method for producing hydroxy-2-butyric acid (Fermentation Engineering Journal, 49(3), 202-205° (1971)
). The chemical production method (1) has problems in the treatment of wastewater containing highly toxic chromium, and countermeasures against pollution are required if it is to be implemented industrially. The method (2) using microorganisms is not suitable for industrial implementation because the yield of 4-hydroxy-2-butyric acid is low at less than 10%, the selectivity is low, and neutral compounds other than the target product are produced as by-products. is inappropriate. Furthermore, the microorganisms used in method (2) are only described as soil bacteria and have not been clearly identified mycologically.
本発明の目的は、収率および選択率に優れな4ヒドロキ
シ−2−ブチン酸の発酵製造法を提供することにある。An object of the present invention is to provide a method for fermentative production of 4-hydroxy-2-butyric acid with excellent yield and selectivity.
【課題を解決するための手段および作用】本発明者らは
、上記課題を解決するため前記従来法(2)で知られた
バクテリア以外の微生物を探索し、特定の糸状菌が2−
ブチン−1,4−ジオールを基質として効率よく4−し
ドロキシ−2−ブチン酸を生成することを見いだし本発
明を完成するに至った。
すなわち本発明は、2−ブチン−1,4−ジオールを基
質として4−ヒドロキシ−2−ブチン酸を生産するリノ
クラディエラ属に属する微生物を2−ブチン−1,4−
ジオールを含む培地に培養し、4−ヒ)−ロキシー2−
ブチン酸を生成せしめ、これを採取することを特徴とす
る4−ヒドロキシ−2−ブチン酸の製造方法に関するも
のである。
本発明に用いられる上記リノクラディエラ属に属する微
生物としては、リノクラディエラ・アトロビレンスK
Y −801(Rh1nocladiella atr
。
virens K Y −801)菌株〔微工研菌寄
第10463号(FERM P−10463)〕があ
る。
本発明者らが得たリノクラディエラ・アトロビレンス■
ぐY−801(微工研菌寄第10463号)の菌学的性
質を以下に示す。
顕微鏡的所見および培地における培養所見ポテトグルコ
ース寒天培地上での成育は遅く、暗灰オリーブ色の羊毛
状またはフェルト状を呈し、裏面はオリーブ黒色である
。
無色ないし褐色の菌糸は隔壁を有し、単独または束状と
なる。菌糸または気中菌糸から分岐して短い分生子柄を
生じ、その先端にシンボジオ型の分生子を形成する。分
生子柄は通常、幅2.2〜3μm前後であるが、600
μmに達する場合もある。中間部がややふくらむものも
ある。
中間に一個の隔壁を有することもあり、また分岐して分
生子柄を形成することもある。菌糸から短い突起を通し
て直接分生子を数個塊状に形成する場合も多い。
分生子は単細胞、倒卵形、共倒卵形、1−4×4.5−
6μmで無色ないし淡オリーブまたは淡褐色、単生また
は塊状に形成される。分生子形成が塊状となるために、
典型的なシンボジオ型が明確に認められず、フィアロフ
ォラ属(Ph1alophora〉の変形かとも考えら
れたが、経時的にスライド培養を観察することにより、
はぼリノクラディエラ属であることが判明した。「菌類
図鑑」 (椿、宇田用著、講談社、1978年)の記載
にほぼ一致するのでリノクラディエラ・アトロビレンス
・ナンフェルド(Rh1nocladiel la
atrovirensNANNFELD )と同定した
。
本発明方法による4−ヒドロキシ−2−ブチン酸の製造
は、2−ブチン−1,4−ジオールを基質として4−ヒ
ドロキシ−2−ブチン酸を生産するリノクラデイエラ属
に属する微生物を2−ブチン−14−ジオールを含む培
地に培養し、4ヒドロキシ−2−ブチン酸を生成せしめ
ることにより行われる。
本発明の実施方法には、2−ブチン−1,4ジオールと
本発明の微生物が資化利用できる栄養素源を含む培地中
に本発明の微生物の接種菌を添加して培養するいわゆる
発酵法と、あらかしめ通常の培地で本発明の微生物を増
殖培養させた後遠心分離等により得られる菌体を添加し
て、2−ブチン−1,4−ジオールを単一炭素源とする
培地で培養させるいわゆる酵素的方法がある。
2−ブチン−1,4−ジオールの培養濃度は、通常0.
5〜10g/ρ、好ましくは2〜5g/ffの範囲で行
う。培養方法は、一般微生物で採用される好気的培養法
であれは特に限定されないが、通常は液体培地による振
とう培養法または通気攪拌培養法が用いられる。
酵素的方法における前培養に用いられる培地としては、
2−ブチン−1,4−ジオールを基質として4−ヒドロ
キシ−2−ブチン酸を生産するリノクラディエラ属の微
生物が資化利用できる栄養源を含有するものであればよ
い。すなわち、炭素源としては、アラビノースなどのペ
ントース類、グルコース、マンノース、フラクトース、
ガラクトースなどのヘキトース類、シュークロース、マ
ルトースなどの三糖類、澱粉分解物、糖アルコール類、
グリセリン、1,4−ブタンジオールなどの多価アルコ
ール類、ポリペプトン、ペプトン、肉エキス、麦芽エキ
ス、酵母エキス、各種アミノ酸、有機酸などが用いられ
る。また、窒素源としては、アンモニア、硫酸アンモニ
ウム、塩化アンモニウム、リン酸アンモニウム、硝酸ア
ンモニウム、硝酸ナトリウム、硝酸カリウムなどの無機
窒素源、またはポリペプトン、ペプトン、肉エキスなど
の有機窒素源が用いられる。また、この他にリン酸水素
二カリウム、リン酸二水素カリウム、硫酸マグネシウム
などの無機塩類を添加してもよい。
培養条件は、特に限定されないが、通常20〜35℃て
10時間〜7日間振どう培養または通気攪拌培養を行う
。
酵素的方法の一実施態様としては、あらかじめ前記の栄
養素を含む培地中で2−ブチン−1,4ジオールを基質
として4−ヒドロキシ−2−ブチン酸を生産するリノク
ラディエラ属の微生物を増殖培養したのち、集菌洗浄し
たものまたは予め凍結乾燥したものを、2−ブチン−1
,4−ジオール水溶液中に懸濁し、振とう培養または通
気攪拌培養すれはよい。また発酵法の場合は、2ブチン
−1,4−ジオールを基質として4−ヒドロキシ−2−
ブチン酸を生産するリノクラディエラ属の微生物の増殖
培養時に直接基質を添加して培養すれ、ばよい。さらに
、アルキン酸ナトリウム、に−カラギーナン、ウレタン
フオームなど゛の担体に2−ブチン−1,4−ジオール
を基質として4−ヒドロキシ−2−ブチン酸を生産する
リノクラディエラ属の微生物を固定化し、固定化菌体と
して用いてもよい。
このようにして、培養液中に蓄積されな4−ヒドロキシ
−2−ブチン酸を分離、採取するには、培養液から菌体
を遠心分離によって分離した後、遠心上清を減圧下に直
接濃縮するか、またはアニオン交換樹脂で吸着分離する
方法を採用すればよいが、これらの方法に限定されない
。
以下、実施例により本発明の詳細な説明する。[Means and effects for solving the problems] In order to solve the above problems, the present inventors searched for microorganisms other than the bacteria known in the conventional method (2), and found that certain filamentous fungi
The present inventors have discovered that 4-droxy-2-butyric acid can be efficiently produced using butyne-1,4-diol as a substrate, and have completed the present invention. That is, the present invention uses 2-butyne-1,4-diol as a microorganism belonging to the genus Rhinocladiella that produces 4-hydroxy-2-butyric acid using 2-butyne-1,4-diol as a substrate.
Cultured in a medium containing diol, 4-hi)-roxy2-
The present invention relates to a method for producing 4-hydroxy-2-butyric acid, which comprises producing butyric acid and collecting it. The microorganisms belonging to the genus Rhinocladia used in the present invention include Rhinocladiella atrovirens K.
Y-801 (Rh1nocladiella atr
. virens K Y -801) strain [FERM P-10463]. Rhinocladiella atrovirens obtained by the present inventors■
The mycological properties of GuY-801 (Feikoken Bibori No. 10463) are shown below. Microscopic findings and culture findings on potato glucose agar media The growth is slow on potato glucose agar media, and exhibits a dark gray-olive woolly or felt-like appearance, with an olive-black underside. The colorless to brown hyphae have septa and may be present singly or in bundles. It branches from the hyphae or aerial hyphae to produce short conidiophores, and symbogeo-shaped conidia are formed at the tips of the conidiophores. Conidiophores are usually around 2.2 to 3 μm wide, but about 600 μm wide.
In some cases, it reaches μm. Some have a slight bulge in the middle. It may have a single septum in the middle, or it may branch to form a conidiophore. In many cases, several conidia are formed directly from the hyphae through short protrusions. Conidia are unicellular, obovate, synovoid, 1-4 x 4.5-
6μm, colorless to light olive or light brown, formed singly or in clusters. Because conidia form in clumps,
The typical symbogeotype was not clearly recognized, and it was thought that it was a modification of the genus Phalophora, but by observing the slide cultures over time,
It turned out to be a genus Rhinocladiella. Rhinocladiella atrovirens Nanfeld (Rh1nocladiel la
atrovirens NANNFELD). In the production of 4-hydroxy-2-butyric acid by the method of the present invention, a microorganism belonging to the genus Rhinocladiella that produces 4-hydroxy-2-butyric acid using 2-butyne-1,4-diol as a substrate is used to produce 2-butyne-1,4-diol. - It is carried out by culturing in a medium containing diol to produce 4-hydroxy-2-butyric acid. The method of carrying out the present invention includes a so-called fermentation method in which an inoculum of the microorganism of the present invention is added and cultured in a medium containing 2-butyne-1,4 diol and a nutrient source that the microorganism of the present invention can utilize. After the microorganism of the present invention is grown and cultured in a normal medium, the microorganisms obtained by centrifugation etc. are added and cultured in a medium containing 2-butyne-1,4-diol as the sole carbon source. There is a so-called enzymatic method. The culture concentration of 2-butyne-1,4-diol is usually 0.
It is carried out in the range of 5 to 10 g/ρ, preferably 2 to 5 g/ff. The culture method is not particularly limited as long as it is an aerobic culture method used for general microorganisms, but usually a shaking culture method or an aerated agitation culture method using a liquid medium is used. As a medium used for preculture in the enzymatic method,
Any nutrient source may be used as long as it contains a nutrient source that can be assimilated by Rhinocladiella microorganisms that produce 4-hydroxy-2-butyric acid using 2-butyne-1,4-diol as a substrate. That is, carbon sources include pentoses such as arabinose, glucose, mannose, fructose,
Hekitoses such as galactose, trisaccharides such as sucrose and maltose, starch decomposition products, sugar alcohols,
Polyhydric alcohols such as glycerin and 1,4-butanediol, polypeptone, peptone, meat extract, malt extract, yeast extract, various amino acids, organic acids, etc. are used. Further, as the nitrogen source, an inorganic nitrogen source such as ammonia, ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium nitrate, sodium nitrate, potassium nitrate, or an organic nitrogen source such as polypeptone, peptone, meat extract, etc. is used. In addition, inorganic salts such as dipotassium hydrogen phosphate, potassium dihydrogen phosphate, and magnesium sulfate may be added. Culture conditions are not particularly limited, but shaking culture or aerated agitation culture is usually performed at 20 to 35°C for 10 hours to 7 days. In one embodiment of the enzymatic method, a microorganism of the genus Rhinocladia that produces 4-hydroxy-2-butyric acid is grown and cultured using 2-butyne-1,4 diol as a substrate in a medium containing the above nutrients, and then 2-butyne-1
, 4-diol aqueous solution and cultured with shaking or stirring with aeration. In addition, in the case of the fermentation method, 4-hydroxy-2-diol is used as a substrate using 2-butyne-1,4-diol.
It is sufficient to directly add a substrate to the microorganisms of the genus Rhinocladiella that produce butic acid. Furthermore, a microorganism of the genus Rhinocladia that produces 4-hydroxy-2-butyric acid using 2-butyne-1,4-diol as a substrate was immobilized on a carrier such as sodium alkinate, carrageenan, or urethane foam. It may also be used as a bacterial cell. In this way, in order to separate and collect 4-hydroxy-2-butyric acid that does not accumulate in the culture solution, the bacterial cells are separated from the culture solution by centrifugation, and then the centrifuged supernatant is directly concentrated under reduced pressure. However, the present invention is not limited to these methods. Hereinafter, the present invention will be explained in detail with reference to Examples.
実施例1
リノクラディエラ・アトロビレンスKY801(微工研
菌寄第10463号)を以下に示す方法により培養した
。
グルコース2g、塩化アンモニウム0.2g、リン酸二
水素カリウム0.02g、硫酸マグネシウム・7水塩0
.02 g、塩化カリウムO,OO2g、硫酸第一鉄・
7水塩0.001g、硫酸マンガン・4水塩0.000
2 g、硫酸亜鉛・7水塩0.0007g、微量の硫酸
銅および微量のビタミンB1 ・、塩酸塩に水道水を加
えて14(pH6,5)に調整し、これを培地とした。
この培地100m1を、500m1容の坂ロフラスコに
秤り取り、120℃、20分間オートクレーブ殺菌した
。この培地にリノクラディエラ・アトロビレンスKY8
01(微工研菌寄第10463号)を−白金耳接種し、
30°CC112Orp、暗所て4日間振とう培養した
。
培養終了後、0.2μmのメンブランフィルタ−で集菌
し、0.1g(乾燥重量)の菌体を得な。これを、0.
2%の2−フヂンー1,4−ジオールの水溶液10m1
に分散させ、30°C112Orpm、暗所で2日間振
とう培養した。遠心分離により菌体と上清に分離し、遠
心上清中の4−ヒドロキシ2−ブチン酸を高速液体クロ
マ1−グラフィーにより定量した結果、生成収率は98
%であり、ブチンニ酸は全く生成していなかった。
遠心上清を減圧下に直接脱水濃縮して単離精製した化合
物の赤外吸収スペクトル、13C核磁気共鳴スペクトル
およびマススペクトルは、全て4ヒドロキシ−2−ブチ
ン酸の構造と一致した。
I R(neat) シmax
3225cm−’(OH)。
2237cm−’(C=C)。
1701cm−’(COOH)
平成1年2月22日Example 1 Rhinocladiella atrovirens KY801 (Feikoken Bacteria No. 10463) was cultured by the method shown below. Glucose 2g, ammonium chloride 0.2g, potassium dihydrogen phosphate 0.02g, magnesium sulfate heptahydrate 0
.. 02g, potassium chloride O,OO2g, ferrous sulfate.
Heptahydrate 0.001g, manganese sulfate tetrahydrate 0.000
2 g of zinc sulfate heptahydrate, 0.0007 g of copper sulfate, and a trace amount of vitamin B1.hydrochloride, tap water was added to adjust the pH to 14 (pH 6.5), and this was used as a culture medium. 100 ml of this medium was weighed into a 500 ml volume Sakaro flask and sterilized in an autoclave at 120° C. for 20 minutes. Rhinocladiella atrovirens KY8 was added to this medium.
01 (Feikoken Bacteria No. 10463) was inoculated with a platinum loop,
The cells were cultured with shaking at 30°C in the dark for 4 days. After culturing, collect the bacteria using a 0.2 μm membrane filter to obtain 0.1 g (dry weight) of bacterial cells. This is 0.
10 ml of 2% aqueous solution of 2-phydine-1,4-diol
and cultured with shaking at 30° C., 112 rpm, in the dark for 2 days. The bacterial cells and supernatant were separated by centrifugation, and 4-hydroxy 2-butyric acid in the centrifuged supernatant was quantified by high-performance liquid chromatography. As a result, the production yield was 98.
%, and no butyndioic acid was produced. The infrared absorption spectrum, 13C nuclear magnetic resonance spectrum, and mass spectrum of the compound isolated and purified by direct dehydration and concentration of the centrifugal supernatant under reduced pressure all agreed with the structure of 4-hydroxy-2-butyric acid. IR(neat) max 3225cm-'(OH). 2237 cm-' (C=C). 1701cm-' (COOH) February 22, 1999
Claims (1)
ヒドロキシ−2−ブチン酸を生産するリノクラディエラ
属に属する微生物を2−ブチン−1,4−ジオールを含
む培地に培養し、4−ヒドロキシ−2−ブチン酸を生成
せしめ、これを採取することを特徴とする4−ヒドロキ
シ−2−ブチン酸の製造方法。(1) Using 2-butyne-1,4-diol as a substrate, 4-
The method is characterized by culturing microorganisms belonging to the genus Rhinocladia that produce hydroxy-2-butyric acid in a medium containing 2-butyne-1,4-diol, producing 4-hydroxy-2-butyric acid, and collecting the same. A method for producing 4-hydroxy-2-butyric acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP155389A JP2709359B2 (en) | 1989-01-07 | 1989-01-07 | Method for producing 4-hydroxy-2-butyric acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP155389A JP2709359B2 (en) | 1989-01-07 | 1989-01-07 | Method for producing 4-hydroxy-2-butyric acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02182193A true JPH02182193A (en) | 1990-07-16 |
JP2709359B2 JP2709359B2 (en) | 1998-02-04 |
Family
ID=11504718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP155389A Expired - Lifetime JP2709359B2 (en) | 1989-01-07 | 1989-01-07 | Method for producing 4-hydroxy-2-butyric acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2709359B2 (en) |
-
1989
- 1989-01-07 JP JP155389A patent/JP2709359B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2709359B2 (en) | 1998-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE30872E (en) | Process for producing 2-keto-L-gulonic acid | |
KR100658396B1 (en) | Novel process for producing l-epi-2-inosose and novel process for producing epi-inositol | |
JP3026190B2 (en) | 5-Aminolevulinic acid-producing microorganism and method for producing 5-aminolevulinic acid using the same | |
US4003794A (en) | Process for producing cholesterol oxidase | |
EP0207636B1 (en) | Process for producing optically active dichloropropanol using microorganism | |
JPH02182193A (en) | Production of 4-hydroxy-2-butynoic acid | |
JP3245254B2 (en) | Novel microorganism and method for producing nootkatone using the same | |
JPH05336979A (en) | Production of p-hydroxybenzoic acid | |
AU655698B2 (en) | Process for producing optically active norborneol | |
JPH0352884A (en) | Fo-608a substance and production thereof | |
JPS5953838B2 (en) | Method for producing β-hydroxyvaleric acid | |
WO1999024439A1 (en) | Novel substance ft-0554 and process for producing the same | |
JP2872311B2 (en) | FO-608B, C substance and method for producing the same | |
JP2993766B2 (en) | Production method of sec-sedrenol | |
JPS62149693A (en) | Antibiotic substance ss42227b and production thereof | |
JPH05279374A (en) | Suidatrestin and its production | |
JPH03197475A (en) | New benzanthracene compound and its production | |
JPS6083591A (en) | Production of sorbitol by fungus of genus aspergillus | |
JPH0378107B2 (en) | ||
JPH0360838B2 (en) | ||
JPS63297398A (en) | Novel physiologically active substance ksa-9342 or its salt, and its production | |
JPS62210996A (en) | Production of antibiotic substance emimycin | |
JPH03183476A (en) | Production of 2-ketobutyric acid | |
JPS5820596B2 (en) | Coproborphyrin 3 No Seihou | |
JPH0716403B2 (en) | Kyandeida Boydini PC-31 stock |